COPD and Asthma Devices Market

Chronic obstructive pulmonary disease (COPD) and asthma devices are useful in inhalation therapy and assist in drug delivery by converting drug suspensions or solutions to aerosolized particles.

COPD and Asthma Devices Market contains market size and forecasts of COPD and Asthma Devices in global, including the following market information:

Global COPD and Asthma Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global COPD and Asthma Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five COPD and Asthma Devices companies in 2021 (%)

The global COPD and Asthma Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Metered Dose Inhalers (MDI) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of COPD and Asthma Devices include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc, AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc, Sunovion Pharmaceuticals Inc and GF Healthcare Products, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COPD and Asthma Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COPD and Asthma Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COPD and Asthma Devices Market Segment Percentages, by Type, 2021 (%)

Metered Dose Inhalers (MDI)

Drug Powder Inhalers (DPI)

Soft Mist Inhalers

Jet Nebulizers

Ultrasonic Nebulizers

Others

Global COPD and Asthma Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COPD and Asthma Devices Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Others

Global COPD and Asthma Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COPD and Asthma Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies COPD and Asthma Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies COPD and Asthma Devices revenues share in global market, 2021 (%)

Key companies COPD and Asthma Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies COPD and Asthma Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GlaxoSmithKline Plc

Novartis AG

Merck & Co., Inc

AstraZeneca Plc

Philips Healthcare

3M Health Care

Allied Healthcare Products Inc

Sunovion Pharmaceuticals Inc

GF Healthcare Products

Smith Medicals

Lincare Holdings Inc

Baxter International